+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study



The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study



Peerj 5: E2943



The current TNM classification system does not consider tumor length for patients with esophageal carcinoma (EC). This study explored the effect of tumor length, in addition to tumor depth and lymph node involvement, on survival in patients with esophageal squamous cell carcinoma (ESCC). A total of 498 ESCC patients who underwent surgical resection as the primary treatment were selected in the retrospective study. Pathological details were collected, which included tumor type, TNM stage, differentiation. Other collected information were: the types of esophageal resection, ABO blood group, family history and demographic and lifestyle factors. A time-dependent receiver operating characteristic (ROC) curve and a regression tree for survival were used to identify the cut-off point of tumor length, which was 3 cm. Univariate and multivariate Cox proportional hazard regression models were used to identify the prognostic factors to ESCC. The 1-, 3-, 5-year overall survival rates were found to be 82.5%, 55.6%, and 35.1%, respectively. Patients who had larger tumor length (>3 cm) had a higher risk for death than the rest patients. From the univariate Cox proportional hazards regression model, the overall survival rate was significantly influenced by the depth of the tumor and lymph node involvement (either as dummy or continuous variables), Sex, and tumor length. Using these four variables in the multivariate Cox proportional hazard regression model, we found that the overall survival was significantly influenced by all variables except Sex. Therefore, in addition to the depth of the tumor and lymph node involvement (as either dummy or continuous variables), the tumor length is also an independent prognostic factor for ESCC. The overall survival rate was higher in a group with smaller tumor length (≤3 cm) than those patients with larger tumor length (>3 cm), no matter what the tumor stage was. The tumor length was found to be an important prognostic factor for ESCC patients without receiving neoadjuvant therapy. The modification of EC staging system may consider tumor length to better predict ESCC survival and identify higher risk patients for postoperative therapy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 060376422

Download citation: RISBibTeXText

PMID: 28168111


Related references

The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. Bmc Cancer 16: 722, 2017

Relative tumor volume is a better independent prognostic factor in esophageal squamous cell carcinoma: Results of a retrospective study. Medicine 98(14): E14963, 2019

Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients. International Journal of Clinical and Experimental Pathology 8(5): 5008-5016, 2016

Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Annals of Thoracic Surgery 91(3): 887-893, 2011

Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma. Annals of Surgical Oncology 19(7): 2149-2158, 2012

Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor?. Upsala Journal of Medical Sciences 118(3): 145-152, 2014

Prognostic and predictive significance of tumor length in patients with esophageal squamous cell carcinoma undergoing radical resection. Bmc Cancer 16: 394, 2017

Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Annals of Surgical Oncology 14(9): 2621-2627, 2007

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Annals of Thoracic Surgery 93(5): 1682-1688, 2012

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma. Medicine 98(9): E14717, 2019

Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma. Tumour Biology 36(9): 6797-6803, 2016

The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma. Oncotargets and Therapy 10: 2729-2736, 2017

Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma. Diseases of the Esophagus 28(5): 496-504, 2016

Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China. Journal of Cancer 7(12): 1663-1667, 2016

Postoperative adjuvant therapy for resectable thoracic esophageal squamous cell carcinoma: a retrospective analysis of 426 cases. Medical Oncology 32(1): 417, 2016